NCT07389265
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07389265 |
| Title | Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer (CAPRI-3 GOIM) |
| Acronym | CAPRI-3 GOIM |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | University of Campania Luigi Vanvitelli |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA | ESP |
CKB BOOST